Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-12 4:36 pm Purchase | 2025-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | Blue Owl Capital Holdings LP | 8,464,663 9.990% | 4,297,834![]() (+103.14%) | Filing History |
| 2026-02-12 4:30 pm Purchase | 2025-12-31 | 13G | Finance Of America Companies Inc. FOA | Blue Owl Capital Holdings LP | 827,409 9.490% | 827,409![]() (New Position) | Filing History |
| 2026-02-12 4:23 pm Sale | 2025-12-31 | 13G | FS Credit Opportunities Corp. FSCO | Blue Owl Capital Holdings LP | 0 0.000% | -50,000![]() (Position Closed) | Filing History |
| 2026-02-12 4:17 pm Sale | 2025-12-31 | 13G | Nuveen Churchill Direct Lending Corp. NCDL | Blue Owl Capital Holdings LP | 2,143,626 4.340% | -947,927![]() (-30.66%) | Filing History |
| 2026-02-12 4:10 pm Purchase | 2025-12-31 | 13G | ImageneBio Inc IMA | Blue Owl Capital Holdings LP | 823,785 7.370% | 282,861![]() (+52.29%) | Filing History |
| 2026-02-12 4:02 pm Purchase | 2025-12-31 | 13G | Biomea Fusion, Inc. BMEA | Blue Owl Capital Holdings LP | 4,451,219 5.920% | 1,951,219![]() (+78.05%) | Filing History |
| 2025-11-14 4:05 pm Sale | 2025-09-30 | 13G | Biomea Fusion, Inc. BMEA | Blue Owl Capital Holdings LP | 2,500,000 3.420% | -1,300,000![]() (-34.21%) | Filing History |
| 2025-11-14 4:05 pm Purchase | 2025-09-30 | 13G | ImageneBio Inc IMA | Blue Owl Capital Holdings LP | 540,924 4.840% | 540,924![]() (New Position) | Filing History |
| 2025-11-14 4:05 pm Sale | 2025-09-30 | 13G | Nuveen Churchill Direct Lending Corp. NCDL | Blue Owl Capital Holdings LP | 3,091,553 6.260% | -947,999![]() (-23.47%) | Filing History |
| 2025-11-05 6:01 pm Sale | 2025-11-03 | 13D | Katapult Holdings, Inc. KPLT | Blue Owl Capital Holdings LP | 21,421 0.470% | -4,285,350![]() (-99.50%) | Filing History |
| 2025-10-29 8:07 pm Purchase | 2025-10-27 | 13D | Katapult Holdings, Inc. KPLT | Blue Owl Capital Holdings LP | 4,306,771 48.550% | 353,995![]() (+8.96%) | Filing History |
| 2025-10-23 8:35 pm Purchase | 2025-10-21 | 13D | Katapult Holdings, Inc. KPLT | Blue Owl Capital Holdings LP | 3,952,776 46.410% | 545,515![]() (+16.01%) | Filing History |
| 2025-10-20 7:43 pm Purchase | 2025-10-16 | 13D | Katapult Holdings, Inc. KPLT | Blue Owl Capital Holdings LP | 3,407,261 42.740% | 539,945![]() (+18.83%) | Filing History |
| 2025-10-14 7:37 pm Purchase | 2025-10-09 | 13D | Katapult Holdings, Inc. KPLT | Blue Owl Capital Holdings LP | 2,867,316 38.580% | 263,869![]() (+10.14%) | Filing History |
| 2025-10-06 8:55 pm Purchase | 2025-09-29 | 13D | Katapult Holdings, Inc. KPLT | Blue Owl Capital Holdings LP | 2,603,447 36.320% | 1,935,762![]() (+289.92%) | Filing History |
| 2025-09-05 4:00 pm Purchase | 2025-08-31 | 13G | Katapult Holdings, Inc. KPLT | Blue Owl Capital Holdings LP | 667,685 12.760% | 667,685![]() (New Position) | Filing History |
| 2025-08-11 5:57 pm Purchase | 2025-06-30 | 13G | Biomea Fusion, Inc. BMEA | Blue Owl Capital Holdings LP | 3,800,000 6.130% | 3,800,000![]() (New Position) | Filing History |
| 2025-05-15 4:13 pm Purchase | 2025-03-31 | 13G | Marker Therapeutics, Inc. MRKR | Blue Owl Capital Holdings LP | 1,127,052 9.990% | 572,802![]() (+103.35%) | Filing History |
| 2025-02-14 5:09 pm Sale | 2024-12-31 | 13G | Sagimet Biosciences Inc. SGMT | Blue Owl Capital Holdings LP | 1,323,877 4.320% | -350,000![]() (-20.91%) | Filing History |
| 2025-02-14 5:09 pm Purchase | 2024-12-31 | 13G | Context Therapeutics Inc. CNTX | Blue Owl Capital Holdings LP | 6,357,928 8.480% | 946,638![]() (+17.49%) | Filing History |

